Chiltern Announces Collaboration with Dr Nawab Qizilbash
December 18, 2009Research and Development
Dr Nawab Qizilbash, MBChB BSc MRCP (UK) MSc Phil (Oxon) is the Director of OXON Epidemiology Ltd. He served as …
Boehringer’s ovarian cancer drug enters phase III
December 18, 2009Research and Development, Sales and Marketing Boehringer, Cancer, ovarian
Boehringer Ingelheim has started a new phase III trial for its investigational cancer drug BIBF 1120. The LUME-Ovar-1 programme will …
UK supports stem cell research with online toolkit
December 18, 2009Research and Development ReNeuron, regenerative medicine, stell cell
A new online resource has been launched to help stem cell researchers in the UK plan a regulatory route for …
Sir Liam Donaldson steps down as England’s chief medical officer
December 18, 2009Liam Donaldson, NHS, UK, appointment
England’s chief medical officer Sir Liam Donaldson will step down in May 2010 after 12 years of service. Details for …
ScopeMedical boosts digital offering
December 18, 2009Medical Communications ScopeMedical, digi
Kent-based med ed agency ScopeMedical has boosted its in-house digital offering and says there are plans to grow it further …
Hospira buys Orchid generic injectables business for $400m
December 18, 2009Manufacturing and Production Hospira, India, Orchid, injectables
Indian active pharmaceutical ingredient manufacturer Orchid Chemicals & Pharmaceuticals has signed a $400 million deal to sell the assets of …
NICE still saying ‘no’ to Roche’s RoActemra
December 17, 2009Sales and Marketing NICE, RoActemra, Roche
Roche will have to present a stronger case for arthritis drug RoActemra in order to gain approval, according to NICE. …
ICON investments will come to fruition in 2010
December 16, 2009Research and Development ICON, Manchester, translational
Irish contract research organisation ICON has provided additional details on its new translational medicine unit in Manchester, UK, first announced …
Digital Pharma: A Year in Digital (5/5)
December 16, 2009Medical Communications 2009, Boehringer, digi, digital pharma, year in review
Favourite use of digital (pharma)• Microsoft’s future of healthcare video. It’s their vision of the possibilities that I fell in …
GSK signs needle-free vaccine alliance
December 16, 2009Research and Development, Sales and Marketing GlaxoSmithKline, Intercell, patch, vaccines
GlaxoSmithKline has signed a deal with Intercell to see whether any of its vaccines could be made available in patch …
Sanofi invests in syringe production in France
December 16, 2009Manufacturing and Production France, Sanofi-Aventis, vaccines
Sanofi-Aventis has doubled its capacity to manufacture syringe-delivered medicines with the opening of new production units at Le Trait, near …
Three new starters at ScopeMedical
December 16, 2009Medical Communications ScopeMedical, appointment, medical communications
ScopeMedical has appointed Toby Galbraith as account director, Carol Richter as medical writer and Chris Tilly as account manager.Toby has …
GSK discloses US healthcare professional payments
December 15, 2009Medical Communications GSK, doctors, industry reputation, payments
GlaxoSmithKline has disclosed some of the fees it has paid to US healthcare professionals for speaking and consulting services.The list …
Digital Pharma: A Year in Digital (4/5)
December 15, 2009Medical Communications 2009, Bayer, digi, digital pharma, year in review
Favourite use of digital (pharma)Physicians’ social networks. This is pharma’s new engagement channel offering the industry an opportunity to normalise …
Commission launches new wave of anti-trust raids
December 15, 2009Sales and Marketing Europe, European Commission, Lundbeck, Teva, generics, kroes
The European Commission has launched a new series of raids on pharmaceutical companies as part of its crackdown on alleged …
The future is personalised
December 15, 2009Research and Development, Sales and Marketing diagnostic, industry, nestle, personalised, pricewaterhousecoopers
A new report says the market for personalised medicine products is set to grow strongly over the next few years, …
Patheon will shed another Puerto Rico plant
December 15, 2009Manufacturing and Production JLL, Patheon, Puerto Rico
Contract manufacturer Patheon has taken the axe to its Puerto Rico operations once again, this time marking its facility in …
Kendle appoints Christopher Bergen chief administrative officer and Simon Higginbotham chief marketing officer
December 15, 2009Research and Development Kendle, appointment, research and development
Kendle has appointed Christopher Bergen to the newly-created role of chief administrative officer and executive vice president.Bergen was previously chief …
AstraZeneca’s Chris Brinsmead and ex-health minister Lord Darzi appointed ambassadors for UK lifescience
December 15, 2009Research and Development, Sales and Marketing AstraZeneca, Darzi, UK, appointment, research and development, sales and marketing
AstraZeneca UK’s chairman Chris Brinsmead and former health minister Lord Ara Darzi are among six newly appointed private sector business …
Vision for £500m biomedical research hub in UK unveiled
December 14, 2009Research and Development Paul Nurse, UKCMRI, Wellcome
Construction of a new biomedical research institute designed to bring the UK to the forefront of fundamental research in a …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
